Thursday, November 12, 2015
ProtocolBuilder, a first-of-its-kind solution for writing clinical trial protocols, has received Gold Awards for “Best New Service Award or Application” and “Health Application” in the 2015 [app] design awards sponsored by design100. The awards celebrate creativity and innovation in design achievements by app creators and commissioners.
Protocol Builder, a cloud-based solution for investigator-initiated clinical trials, now is available to individual researchers, including medical residents and fellows, according to the Biomedical Research Alliance of New York (BRANY), the developer of the system and a national organization providing clinical research support solutions such as IRB review, trial contracting/budgeting, and auditing and monitoring to hospitals and academic medical centers.
The Biomedical Research Alliance of New York (BRANY), the developer of Protocol Builder, has appointed Christopher Olsen as senior director of national sales and marketing. Olsen will be responsible for sales and marketing efforts with academic medical centers, health systems, hospitals and individual clinical investigators.
BRANY has successfully continued its full accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The five-year accreditation reflects BRANY’s continuing commitment to protecting the rights and welfare of research participants. AAHRPP’s accreditation process helps organizations consistently meet ethical principles and standards for protecting research participants.
The Biomedical Research Alliance of New York (BRANY), a national organization providing expedited end-to-end solutions for clinical trials support to sponsors and investigators, and the nonprofit Alliance for Clinical Research Excellence and Safety (ACRES), have announced a strategic alliance.
The Biomedical Research Alliance of New York (BRANY), a network of clinical research sites in the U.S., has collaborated with ViS Research, which offers an online research feasibility platform that eliminates feasibility questionnaires, to help researchers by reducing their administrative tasks related to feasibility questionnaires while providing faster and easier trial startup.